Welcome to Demei Chemical Technology Co., Ltd
📞 +86-0536-2205782 📧 arron.seagulls@gmail.com
Language: English | Japanese | Russian

7-Hydroxy-2H-chromen-2-one

CAS No.: 93-35-6

  • Molecular Formula: C₉H₆O₃
  • Molecular Weight: 162.14 g/mol

Chemical type

  • Coumarin (7-hydroxycoumarin)
[1]
  • Natural coumarin
[2]

Key properties

  • Chemosensory substance; inhibitory effects on fungi (e.g., Botrytis cinerea) and invasive plants (e.g., Stellera chamaejasme); produced via hydrolysis of skimmin by β-glucosidases; analogs contribute to plant immunity and stress response.
[1]
  • Exhibits anti-inflammatory, anticancer, and metabolic regulatory activities
  • Metabolism influenced by genetic variation in CYP450 enzymes
[2]
  • Plant defense against pathogens and herbivores; potential in suppressing toxic plant spread; active ingredient in Angelica dahurica with pharmacological effects.
[1]
  • Traditional medicine
  • Investigated for anti-inflammatory and anticancer effects
[2]

Classification by use

  • Chemicals involved in plant defense and immunity
[1]
  • Natural product
  • Investigational therapeutic compound
[2]

A trustworthy factory and manufacturer

Demei Chemical Technology Co., Ltd. is a modern high-tech enterprise integrating R&D, production, and sales. The company's founder, Dr. Arron, born in April 1975, graduated from the School of Mechanical Engineering at Yanshan University and has been engaged in research in the fields of mechanical engineering and chemical synthesis for many years. The company's products focus on the chemical industry, primarily dealing in chemical raw materials and chemical production machinery and equipment. With its strong technical capabilities, advanced production equipment, and strict quality management system, the company has earned the trust of customers worldwide.

  1. [Cite:1] A novel beta-glucosidase gene from Angelica dahurica and insights into the metabolic pathway of scopoletin, Industrial Crops and Products, Volume 231, 1 September 2025, 121219
  2. [Cite:2] Coumarins and Precision Medicine: Molecular Mechanisms and Pharmacogenomics in Patient-Specific Therapeutic Design, Precision Medicine and Engineering, 2 February 2026, 100059